Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Serious side effects are rare but may include elevated liver enzymes or gallbladder issues
Any prescription drugs meant to treat obesity were not included in the plan even if the drugs were considered medically necessary
Even modest weight loss achieved through Semaglutide GLP-1 treatment can significantly enhance health outcomes for obese and overweight patients
Frequently used in laboratory research involving anabolic signaling
International Diabetes Federation (IDF)
The injection remains the leading recombinant hormone in fertility treatment and continued to perform well for Merck KGaA in 2022, having garnered 825 million ($869 million USD) in global net sales by the end of 2022
US$ 22.37
US$ 28.54
US$ 23.69
US$ 25.92
